ANNUAL MEETING ABSTRACTS and compared EGFR and Akt pathway activation with EGFR mutation status. Slides were immunostained with activation-state specific antibodies, including antibodies to phospho-EGFR, phospho-tyrosine and phospho-Akt.12 cases were subjected to EGFR DNA sequencing. Results: High EGFR phosphorylation of all the tyrosine sites probed and phosphorylated Akt were detected in mutant EGFR cell xenografts but not in xenografts containing cell lines with wild type EGFR. IHC analysis of general phospho-tyrosine, phospho-EGFR and phospho-Akt on a NSCLC TMA found phosphorylated EGFR in 15%-25% of patient samples, depending on the tyrosine site. Phosphorylated EGFR was more frequent in adenocarcinomas (20%-30%) and in bronchoalveolar carcinomas (BAC)(28%-50%) than in squamous cell carcinomas (SCC)(5%-10%). The phospho-EGFR reactivity was closely correlated with high general phospho-tyrosine reactivity. There was also a strong correlation between high phospho-EGFR staining and high phospho-Akt staining in patient specimens. EGFR kinase domain DNA sequencing revealed that a majority of these samples were mutant. Conclusions: These results suggest that mutant EGFR is constitutively phosphorylated and activates downstream Akt in NSCLC; therefore, IHC analysis of phosphorylated EGFR and Akt may reflect the activation of mutant EGFR signaling in patient samples. Design: A series of 61 thymic neoplasms were reviewed and classified according to World Health Organization (WHO) scheme. Key clinical information including patient survival, Masaoka's staging, disease local recurrence, treatment modality, and WHO histology subtype was obtained. Percentage of membranous expression of α-catenin, β-catenin, E-cadherin and EGFR were recorded. While staining <80% of the cells was considered reduced expression for α-catenin, β-catenin, and E-cadherin, EGFR was considered positive when >10% of tumor cells expressed the antibody. Correlation of expression of markers and clinicopathologic variables was statistically analyzed using Spearman rank correlation and Kaplan-Meier analysis. Results: Fifty seven patients had available long follow up records. There were 6 type A, 15 type AB, 7 type B1, 6 type B2, 17 type B3, and 9 type C tumors. Six of fifty seven patients died of the disease. Six patients developed local relapse. The reduced expression rate of α-catenin, β-catenin, E-cadherin was 77.2%, 78.9%, and 89.5% respectively in all subtypes. Expression of α-catenin was significantly reduced (<30%) in patients who died of the disease (p=0.04). Expression of β-catenin closely correlated with α-catenin, and E-cadherin (p<0.001 each). Epidermal growth factor receptor was positive in 56.1% of total cases with no significant correlation with various prognostic variables.
10 BEC. Sample quality (poor fixation, inflammation, blood or mucous) was recorded. Patient records were reviewed for bronchoscopic findings and tumor size. Results: Number of BEC, bronchoscopic findings and tumor size are summarized in table I. The most important predictor of positive cytology was bronchoscopic visualization of lesion in BB (P<0.001) and lack of visualization in BW (P <0.04). The number of BEC and tumor size did not correlate with positive diagnosis in either BB or BW. When compared to BB, BW is more likely to have positive diagnosis in nonvisualized lesion (10 versus 5 cases). Bronchoscopy findings for 4 cases and tumor size for 2 cases were not available. Drying artifact was present in most BB smears. Blood, inflammation, or mucous didn't preclude a diagnosis in any case. Conclusions: 1-In this limited study there is no correlation between the number of BEC and diagnostic yield. 2-Bronchoscopic visualization of lesion is predictive of positive diagnosis. BB is most diagnostic in visualized lesions and BW in nonvisualized lesions. Utilization of bronchoscopic findings may allow for specimen enrichment by the bronchoscopist and/or specimen triage by the cytology lab. Background: Cytology labs upon request provide on-site specimen adequacy evaluations assuming that they improve diagnostic yield. So far, the literature on this issue has been controversial and the cost-effectiveness of this practice remains unclear. Therefore, we have examined our own experience to assess its efficacy. Design: Cytology reports on all image-guided non-thyroid fine needle (FNA) and core biopsies from January through June 2005 were retrieved. The specimens were divided into two categories: those with and without adequacy evaluations. Organ site, type of specimen (FNA or core), and final cytologic diagnosis were recorded for all specimens. For those with evaluations, the result of evaluation, and number of passes were recorded. Results: 250 specimens were accrued during the study period from kidney (16), liver (42), lung (50), pancreas (51), retroperitoneum (7), and soft tissue (84 Conclusions: Overall, the approach of maintaining the chain of patient identity at each step resulted in significant improvements. Specifically, non-batching, verification of multiple patient identifiers, physical separation of specimens and the culture of increased awareness have been particularly effective. The practice of proper specimen handling is being enforced with routine in-service education to eliminate the human error, still a significant risk factor despite marked improvement in the specimen handling process.
Are Routine
Step Sections of All Bronchoscopic Biopsies Required? E Dunkailo, J Weydert. University of Iowa Hospitals and Clinics, Iowa City, IA. Background:
Step sectioning is a common practice in surgical pathology that has proven useful in increasing the diagnostic yield of biopsy material. The manner and extent of step sectioning varies by practice. Conservative step sectioning may limit diagnostic sensitivity, while extensive step sectioning may generate extraneous numbers of glass slides, especially in high volume practices. At our institution, we routinely step section all bronchoscopic biopsies, generating 3 H and E stained slides and 3 unstained slides on each tissue block. We sought to clinically validate this protocol with regard to diagnostic yield. Design: Retrospective blinded review of routinely step sectioned bronchoscopic biopsies (39 cases, 52 total tissue blocks). Each of the following were documented: 1) pathologic diagnosis; 2) the number of step sections required to reach the diagnosis in an unequivocal manner; and 3) whether the saved unstained step sections were utilized for ancillary studies.
Results:
The pathologic diagnoses of each tissue block were categorized as follows: malignancy, 30 blocks; reactive and/or dysplastic squamous changes, 6 blocks; granulomatous inflammation and/or specific organism, 10 blocks; no diagnostic abnormality, 6 blocks. In the cases of malignancy, 97% (29 of 30) were detected on the first section, and 100% by the second. In contrast, all three step sections were required for unequivocal diagnosis in 3 cases of granulomatous inflammation (see table) . Ancillary studies were performed in 17 cases, but in only 5 of these were the unstained step sections utilized for the ancillary studies.
Diagnostic yield as a function of number of step sectioned slides Malignant (30) Reactive/dysplasia (6) Granuloma/organism (10 
Conclusions:
The data indicates that routine step sectioning increases diagnostic yield in bronchoscopic biopsies. However, the extent of step sectioning required varied by diagnostic category, and importantly all malignancies and dysplasias were detected by step two. A routine two-slide step sectioning protocol would be most appropriate in the evaluation of bronchoscopic biopsies, with additional sections performed in cases that reveal findings suspicious for granulomatous type inflammation. The protocol should also include a statement regarding the use of unstained steps for ancillary studies. 
Enhancement of Imprint Cytology with Immunohistochemistry and Fine Needle Aspiration in Intraoperative Evaluation of Sentinel Lymph Nodes for Metastatic Malignant Melanoma
Background: Staging of malignant melanoma (MM) by intraoperative evaluation of sentinel lymph nodes (SLNs) allows for a one-step regional lymph node dissection to be performed when the SLN findings are positive. Frozen section examination of the SLNs in MM is not recommended because of the potential loss of SLN tissue containing a small micrometastatic focus. Intraoperative imprint cytology (IIC) has been recommended as an alternative to frozen section and has become a routine practice for evaluation of SLNs at our institution. The limitation of IIC for evaluation of SLNs for MM is its low sensitivity (10-30%). The reason for this could be a low yield of neoplastic cells by IIC, or a decreased recognition of cells by cytologic methods. This study was done to determine 1) the sensitivity of IIC at our institution as well as whether 2) immunohistochemistry on routinely negative slides could play a role to enhance detection and 3) whether a bench top fine needle aspiration (FNA) could increase yield of neoplastic cells over use of the IIC. Design: Routine evaluation of SLN including IIC, H&E permanent sections and immunohistochemistry (HMB 45) was performed for 354 patients with MM from November, 2002 to September, 2005 . At the time of intraoperative consultation, after routine IIC slides were prepared, bench top FNA was performed in 25 patients with MM starting from July of 2005. These sections were immunostained with HMB 45 and melan A. Results were compared with those of the IIC, H&E and HMB 45 immunostained sections. Results: SLN positivity was 10.7% (38/354). IIC was helpful in detecting occult MM in 32% (in 12 of the 38 positive SLNs identified on permanent sections). There was one false positive IIC (specificity of 97%). Of the 25 patients with a negative routine IIC, one showed micrometastasis on H&E stained sections. This was detected by immunostains with HMB 45 and melan A on additional touch preparations and on bench top FNA which was confirmed by H&E and HMB 45 immunostained sections. Conclusions: Although it has a low sensitivity, IIC is a valuable method of intraoperative evaluation of SLNs, which can spare nearly one-third of the patients with clinically occult regional metastases from a second surgery. At this stage, a low positivity rate in our accrued cases does not allow any conclusion as to the efficacy of additional cytologic sampling and immunocytochmical procedures. Further studies are in progress to assess this.
Design: Of 103 specimens, 7 were excluded for acellularity.[ 4 BBs and 3FNAs]; 2 BBs and 2 FNAs were excluded for yielding indeterminant diagnoses, a tertium quid the clinician never chose. For the remaining 92 specimens [9BBs, 37BWs, 29FNAs and 17Bxs], the pulmonologist catagorized the results he anticipated as either likely or unlikely to be malignant. Concordances with cytologic or histologic diagnoses were then calculated by procedure type and overall. Results: All 9 BBs were projected to be malignant, 6/9 BBs were Background: Robotic prostatectomy is a minimally invasive and sophisticated surgical method for removing the prostate using a robotic device. As far as we know, there have been no published studies comparing blood loss in robotic and non-robotic prostatectomies. In our institution, all elective prostatectomies (robotic and nonrobotic) automatically trigger 2 units of typed and crossmatched blood reserved for these patients in anticipation of blood loss, according to the institution's Maximum Surgical Blood Order Schedule (MSBOS). Design: All radical prostatectomies in our institution from January 2003 to August 2005 were analyzed for intraoperative blood usage. Results: Blood loss during the da Vinci (Intuitive Surgical, Inc., Sunnyvale, CA) robotic assisted prostatectomies was minimal. None of the 31 (0%) robotic prostatectomies required blood transfusion. On the other hand, each of the 12 traditional open radical prostatectomies performed (100%) required 2 units of crossmatched blood intraoperatively. One (1) laparoscopic radical prostatectomy was performed during this period, for which transfusion of 2 units of crossmatched blood was also required (100%). Conclusions: Robotic prostatectomy is gaining popularity around the nation as a less invasive way of removing the prostate for cancer than open surgery. It allows the surgeon to remotely and precisely control the movements of instruments positioned inside the patient through small incisions. Our findings indicate that robotic prostatectomy has the advantage of reducing intraoperative blood loss (0% transfusion requirement) compared to non-robotic procedures (100% transfusion requirement). While most blood products are safe and most transfusions are uneventful, blood transfusions are not entirely risk-free. This study suggests that preoperative typed and crossmatched blood for robotic prostatectomy may be safely replaced by a simpler "type and screen" process in the blood bank. This could represent an opportunity for improving efficiency in the blood bank by decreasing unnecessary crossmatching and decreasing wastage of expired blood products. However, additional blood usage data based on a larger series of robotic prostatectomy would be necessary to ultimately effect a change in our blood order protocol. Future studies should also include blood usage in other types of minimally invasive robotic-assisted surgeries. . Inter-and intraobserver variability with IHC evaluation can affect the number of FISH assays performed. As diagnostic algorithms are expensive and impact patient care, we evaluated the effects of assisted cellular image analysis (ACIS) on reflex Her-2/neu FISH testing. Design: ACIS was standardized using 40 cases interpreted with Her-2/neu IHC that covered the spectrum of 0+ to 3+ staining with 2+ FISH correlation. Standardized IHC for Her-2/neu was performed on 373 sequential cases that were divided into two groups: 1. traditional interpretation (Pre-ACIS group; retrospective cases); and 2. imaging assisted interpretation (ACIS group; prospective cases). Testing was performed according to the manufacturers' recommendations (Ventana Medical Systems and ChromaVision, Clarient Inc.). Pre-ACIS group demographics (n=137): Age: 59±13 yrs; Tumor size: 2.6±2.2 cm; modified Bloom-Richardson grade 1 (22%), 2 (44%), and 3 (34%); ER-positive 71%; and PR-positive 63%. ACIS group demographics (n=236): Age: 58±13 yrs; Tumor size: 2.5±2.2 cm; modified Bloom-Richardson grade 1 (16%), 2 (53%), and 3 (31%); ER-positive 77%; and PR-positive 62% (Pre-ACIS vs ACIS demographics p = 0.414).
Image Analysis of Her-2/neu Expression Improves Case Selection for Reflex FISH Testing in Breast Cancer

Results:
Comparision of Her-2/neu Scoring with FISH Amplificaton Her-2/neu Score (% Results: There were 73 responses, the majority (ranging from 55 to 91%) agreed on the need for a phone call ASAP for the following dx: crescents in kidney biopsy, vasculitis, bacteria in heart or bone marrow, organisms in immunocompromised patients, uterine contents without villi or trophoblasts, fat in endometrial curettage, mesothelial cells in heart biopsy, fat in endoscopic colon polypectomies, transplant rejection, malignancy in superior vena cava syndrome, and neoplasms causing paralysis. For new dx of malignancy with clinical suspicion and for new dx of metastasis with known primary malignancy, most participants agreed that there was no need for a phone call. In some dx (organisms in immunocompetent patients, and large vessel in core biopsy specimen), there was disagreement about the need for a phone call. For disagreement between frozen section and final dx and for completely unexpected malignancy, most participants agreed on the need for a phone call, but disagreed on the degree of urgency. Several additional CVs were suggested as well as discussion of best terminology for critical values, appropriate documentation of phone calls, urgency of call depends on details of dx (which microorganism; grade of transplant rejection; if disagreement between frozen section and final dx is significant, etc). 5 of 73 pathologists said they didn't believe in the concept of CV in SP, 3 of which expressed concern about medicolegal implications.
Conclusions: There was good agreement about most of the possible CVs, although there was difference of opinion for some dx. (n=431) . Interobserver variability between the first and second cytologist diagnosis was measured using the kappa statistic. Two-step or more differences in diagnosis were arbitrated as interpretive errors and the effect of double viewing was measured by comparing the frequency of cytologic-histologic correlation-detected errors in the previous 2 years to the double viewing period. The use of non-definitive diagnoses (e.g., atypical and suspicious) also was measured in the project sites. Results: Using double viewing, the number of interpretive errors detected for the institutions was 2.7%, 0%, and 1.9%, respectively. The pairwise kappa values between the first and second cytologist varied from 0.81 and 0.95, indicating excellent agreement. Double viewing did not lower the frequency of cytologic-histologic correlation false negative errors when data from the double viewing period were compared to data from the previous 2 years. During the double viewing period, the aggregated 2-step diagnostic error proportion was 25.2% of all cytologic-histologic correlation pairs. Based on the cytologic-histologic correlation process, a 2-step or greater difference in diagnosis was observed in 23. Background: There is little published data on the value of measuring frozen-section discordant and deferral rates by multiple institutions over time. Design: Participants in the College of American Pathologists' Q-TRACKS program self-reported the number of anatomic pathology frozen-permanent section discordant and deferred cases in their laboratory by prospectively performing secondary review of intra-operative consultations. One hundred seventy-four laboratories self-reported data. Laboratories participated in the program from 1 to 5 years and reported their data every quarter. We calculated mean and median discordant and deferred case frequencies and used mixed linear modeling to determine if length of participation in the program was associated with improved performance.
The mean and median frozen-permanent section discordant frequencies were 1.36% and 0.70%, respectively. Longer participation in the Q-TRACKS program was significantly associated (P = .0401) with lower discordant frequencies; 4 or 5 year participation showed a decrease in discordant frequency of 0.99% whereas 1 year participation showed a decrease in discordant frequency of 0.84%. Longer participation in the Q-TRACKS monitor was associated with lower microscopic sampling frequencies for discordant diagnoses (P = .0351). The mean and median deferred diagnostic frequencies were 2.35% and 1.20%, respectively. Increased length of participation in the Q-TRACKS program was significantly associated (P = .0437) with lower deferred diagnostic frequencies. Conclusions: Long term monitoring of frozen-permanent section correlation is associated with sustained improvement in performance.
Evaluating the Amended Report in Surgical Pathology
CT Rossi, SO Tabbara. George Washington University, Washington, DC. Background: Quality assurance in surgical pathology evaluates the impact on patient care of errors in the delivery of diagnosis and aims at improving pathologists' and departmental performance. This study focuses on one indicator, the amended report. Design: A laboratory information system (LIS) search of 18,000 accessions located 121 amendments, which were categorized by the reason for the revision as recorded by the reporting pathologist. Errors were analyzed for their potential impact on patient care. Results: Amendments occurred in 0.7% of accessioned cases, mainly involving breast (34/121-28%) and skin (14/121-12%) cases. Table 1 shows the reasons for amendments. Changes to the final diagnosis, laterality, specimen site and patient demographics amounted to 49 (40.2%)cases and were considered of significant impact on patient care if undetected. The majority of final diagnosis changes remained within the same diagnostic category (15/27-55.6%) and had no effect on patient care. Two (7.4%) final diagnoses were prematurely released and 2 (7.4%) lacked explanatory information. However in 8/27 (29.6%) cases a change from benign to malignant, from neoplastic to non-neoplastic or vice versa was made and carried a potential impact on patient care. Modification of 43 (35.5%) reports lacked a clear categorization of the error ("typographical error," or no documentation provided). The remaining 29 (23.9%) cases involved minor issues. Overall a statement reconciling original and amended report was lacking and significant differences in documentation practices were observed among pathologists. Conclusions: Review of amended reports is a useful QA indicator to evaluate errors in surgical pathology. This study documents a low incidence of errors requiring amendment of surgical pathology reports and ultimately no significant impact on patient care. It detected serious flaws in the LIS documentation of amended reports, mainly lack of retention/accessibility of the original report, the absence of a detailed log of each amendment, and overall incomplete or ambiguous documentation by the pathologists of the reason for amendment. Such practices may be avoided by establishing welldefined categories for reasons for amendment, and explicit, possibly templated, documentation of the modifications. The cases presented at the conference are selected by the AP director based on: discordance between final diagnosis (dx) and preliminary FNA or frozen section dx ; amended dx; discordant second opinion dx; discordance between cytology and surgical pathology dx; technical problems; reporting and terminology issues; and physician complaints. For the current study, we reviewed the cases presented at the past 6 months conferences and classified as to problem type and implemented further action.
Results: During this 6 month period, there were 110 cases presented at the conference: 95 surgicals, 13 non-gyn cytology, 1 gyn cytology and 1 bone marrow. During this 6-month period there were a total of 8656 surgicals, 1547 non-gyn cytology and 5002 gyn cytology specimens. The cases were categorized into 15 different types of problems: terminology (11 cases); clerical error (15 cases); technical error (0 cases); incomplete examination -gross or micro (5 cases); incomplete or inadequate report (23 cases); incorrect tumor classification (12 cases); incorrect tumor grade (1 case); incorrect tumor staging (8 cases); overcall (10 cases); undercall (11 cases); incorrect outside dx (4 cases); other clinically significant incorrect dx (5 cases); other clinically insignificant incorrect dx (3 cases); inappropriate use of stains (1 case); and consult should have been obtained (1 case). Also analyzed for each case was further actions taken: amended report (31 cases); addendum (35 cases); additional immunostains (7 cases); additional gross examination (4 cases); additional levels (2 cases); review of case (2 cases); comment in the dx (2 cases); physician contacted (14 cases) and no action (41 cases).
Conclusions:
The institution of a monthly AP Quality and Safety Conference is pathology's version of the educational and process improvement "Morbidity and Mortality" clinical conference. Although many of the issues presented are also handled on an individual basis, we believe there is educational value for group presentation and discussion when conducted in a constructive, non-threatening environment.
1509 Amended TNM Staging of Synchronous Lung Cancers after Molecular Analysis JF Silverman, TC Pereira, YL Liu, SD Finkelstein. Allegheny General Hospital, Pittsburgh, PA; RedPath Integrated Pathology, Pittsburgh, PA. Background: Multiple lung carcinomas (CAs) of the same histologic type are considered synchronous if they involve separate lobes with no evidence of extra-thoracic disease, mediastinal lymph node metastases, or of nodal metastases with a common nodal drainage. Synchronous tumors should be staged separately. However, if multiple tumors are in the same lobe, they are staged as T4 and therefore represent stage IIIB disease. However, metastatic CA (M1) would be stage IV. In this study, we evaluated changes in TNM staging based on molecular analysis of synchronous lung CA. Design: We retrieved paraffin blocks of 24 CA from 12 patients. The CA in each patient were of the same histologic type (10 adenocarcinomas, 8 squamous cell carcinomas, 4 large cell carcinomas, and 2 small cell carcinomas). 4-8 microdissection targets from neoplasm and non-neoplastic controls were removed under stereoscopic guidance and analyzed by PCR for LOH at 1p, 3p, 5q, 9p, 10q, 17p, 17q, 21q, 22q and point mutation determination in k-ras-2 . The tumors were classified as de novo or metastasis based on 3 levels of concordance: (1) marker affected -tumors were considered concordant if 50% of more of the same markers were mutated, (2) same gene copy affected, and (3) temporal sequence of mutation. The tumors were staged according to the 6th edition of the AJCC Cancer Staging Manual.
